RGB-14-P (denosumab biosimilar) / Gedeon Richter - LARVOL DELTA

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis (clinicaltrials.gov) - P3 | N=473 | Completed | Sponsor: Gedeon Richter Plc. | Active, not recruiting ➔ Completed

Trial completion • Osteoporosis • Rheumatology

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis (clinicaltrials.gov) - P3 | N=473 | Active, not recruiting | Sponsor: Gedeon Richter Plc. | Recruiting ➔ Active, not recruiting | Trial primary completion date: Jun 2023 ➔ Nov 2023

Enrollment closed • Trial primary completion date • Osteoporosis • Rheumatology